NCT01837498View on ClinicalTrials.gov

Reversal of Neuromuscular Blockade in Thoracic Surgical Patients

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Residual Neuromuscular Blockade
Interventions
DRUG

Neostigmine

At the conclusion of the surgical procedure, neuromuscular block will be reversed with neostigmine

DRUG

Sugammadex

At the conclusion of the surgical procedure, neuromuscular block will be reversed with sugammadex

Trial Locations (1)

60201

NorthShore University HealthSystem, Evanston

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
lead

Endeavor Health

OTHER

NCT01837498 - Reversal of Neuromuscular Blockade in Thoracic Surgical Patients | Biotech Hunter | Biotech Hunter